Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Major infrastructure development planned for three campuses
2014-01-06

 

DHET Sound Studio, African Languages and Humanities projects.
More students will be accommodated on our campuses, with two new residences being built on the Qwaqwa and Bloemfontein Campuses respectively. The residences are part of a grant received by the Department of Higher Education and Training (DHET).

The new residences will accommodate 250 students each and the planned completion date is end of 2014.

Other major projects planned for the three campuses are a Student Life Centre on the Qwaqwa Campus, new lecture halls for the South Campus and a new sound studio on the Bloemfontein Campus. The sound studio will be erected where the old squash courts used to be.

The Department of Physical Planning stated the aim is to create a facility that can house a recording studio that will function as a multi-purpose centre where students can get practical experience in sound and visual recording. Albie Louw, Chief Officer: Property Management in the Department of Physical Planning, says the studio will have a screening room, a multi-camera recording studio, editing room, video- and audio-control room and lecture-recording studios.

The projects have different completion dates, but all fall within the 2013/2014 and 2014/2015 financial years.

On the Qwaqwa Campus, the existing amphitheatre in front of the library will get a roof, so that it can be used more effectively and be more accessible. It will create a new active open space that can be utilised by students for informal study, a social space and for formal functions or promotions.

Other facilities to be upgraded include the electrical infrastructure on the Qwaqwa Campus. Disability access on the campus will also be improved.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept